Intimation of ESG Rating

Ref: Akums/Exchange/2026-27/48 September 03, 2026 To, To, The Listing Department The Listing Department National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001 Symbol: AKUMS Scrip Code: 544222 Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – ESG Rating Respected Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated July 11, 2023 (updated on January 30, 2026), this is to inform you that on September 02, 2026, the Company has received an ESG rating of “65” for the Financial Year 2025-26 from NSE Sustainability Ratings & Analytics Limited (“NSE Sustainability”), a subsidiary of NSE Indices Limited and a registered ESG Rating Provider. Please be informed that the Company has not engaged NSE Sustainability for ESG Rating and they have voluntarily assigned the aforesaid ESG Rating on the basis of publicly available information. The link of the ESG rating is https://www.nse-esgrating.com/esg-ratings/552?fiscalYear=2024-2025. This is for your kind information and record. Thanking You Yours Faithfully For Akums Drugs and Pharmaceuticals Limited Dharamvir Malik Company Secretary & Compliance Officer